Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial

Next Previous
Trial Profile

The Impact of the Continuous Infusion of Intraperitoneal Analgesics on Postoperative Pain After Minimally Invasive Hysterectomy: a Randomized Controlled Trial

Status: Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2023

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Ropivacaine (Primary) ; Ketorolac
  • Indications Postoperative pain
  • Focus Therapeutic Use
  • Acronyms ON-Q

Most Recent Events

  • 06 Nov 2023 Planned primary completion date changed from 1 Sep 2023 to 1 Sep 2024.
  • 25 Jul 2022 Planned End Date changed from 1 Dec 2021 to 1 Sep 2023.
  • 25 Jul 2022 Planned primary completion date changed from 1 Dec 2021 to 1 Sep 2023.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top